Vaccine stocks rally on report of NIH personalized cancer-vaccine push
Vaccine-linked shares rose after a report detailed a national push to speed personalized cancer vaccines, with Novavax, Moderna and BioNTech among the gainers.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally
A nationwide initiative to accelerate personalized cancer vaccine development is drawing fresh investor interest in vaccine makers, sending several biotechnology and pharmaceutical stocks higher Friday. Moderna, Inc. (NASDAQ: MRNA ), Novavax, Inc. (NASDAQ: NVAX ), BioNTech SE (NASDAQ: BNTX ), Pfizer Inc. (NYSE: PFE ),